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Zika virus has been spreading rapidly in Brazil and 
the Americas, with a sharp increase in the number of 
notiﬁ ed microcephaly cases since September, 2015.1,2 
Based on the high number of cases, and the association 
between Zika virus infection and microcephaly,3,4 WHO 
on Feb 1, 2016, declared a Public Health Emergency 
of International Concern.5 Recently, animal models 
have shown that the Brazilian Zika virus strain causes 
intrauterine growth restriction and microcephaly.6
An emerging disease such as Zika virus infection, with 
severe consequences for newborn babies, is already 
a major challenge for public health authorities for 
countries as large as Brazil. But the eﬀ ect of the current 
epidemic is expected to be even more devastating, 
considering the current Brazilian economic crisis and its 
potential impact on the already chronically underfunded 
Brazilian health system.7 Eﬀ ective evidence-based health 
surveillance systems are needed.
In the context of several scientiﬁ c and public 
health uncertainties regarding Zika virus infection, 
Giovanny França and colleagues’8 paper in The Lancet 
is welcome. Using data from the Brazilian Ministry of 
Health surveillance system for microcephaly, the study 
describes clinical and anthropometric characteristics of 
the largest case series of suspected Zika virus infection 
reported so far. Among a total of 5554 liveborn 
infants with suspected microcephaly, the study 
includes data for all 1501 suspected cases (27%) with a 
complete investigation.
Compared with discarded cases (all cases that were not 
included in the categories as probable cases; n=899), 
deﬁ nite and probable cases (n=602) showed smaller head 
circumference and their mothers were more likely to refer 
rash during pregnancy. Interestingly, some 20% of the 
deﬁ nite or probable cases had normal head circumference 
values, and for a third of them, a rash had not occurred 
during pregnancy. Based on these results, the authors 
recommend that a surveillance system aimed at 
detecting all aﬀ ected newborn babies should not simply 
focus on microcephaly and rash during pregnancy.
The paper by França and colleagues8 is an important 
contribution for improving the surveillance system for 
congenital Zika virus infection. However, caution should 
be taken in interpreting results of this case series based 
on routinely collected data with missing information for 
many cases and an unknown degree of under-reporting.
Based on the cutoﬀ  for head circumference below –2 SD 
(Z values, InterGrowth standards), the study provides a 
sensitivity estimate of 83% for identifying deﬁ nite or 
probable cases. There is potential bias in the estimates 
provided for sensitivity and speciﬁ city due to the way 
that participants were selected for the study. Most 
participants included in the analyses were reported on 
the basis of a preselection screening for microcephaly, 
a predictor of congenital Zika virus syndrome. Because 
small head circumference is being evaluated as an 
indicator, the incorporation of a correlate (microcephaly) 
in the selection of participants might have overestimated 
sensitivity. Systematic follow-up studies during pregnancy 
and the ﬁ rst years of life will be needed to provide more 
accurate sensitivity estimates of the proposed criterion.
Concerning speciﬁ city, the authors’ estimate of 98% is 
also debatable. Based on the InterGrowth standards, one 
would truly expect 2% of normal newborn babies having 
microcephaly using the proposed cutoﬀ . However, 98% 
is not the expected speciﬁ city for ruling out congenital 
Zika virus syndrome among suspected cases, but the 
speciﬁ city for pathological microcephaly.
For incorporating new information besides 
microcephaly and rash during pregnancy to detect all 
aﬀ ected cases, neurological signs and symptoms could 
be eligible, but might be diﬃ  cult to obtain in most 
settings because of insuﬃ  cient specialised personnel. 
The development of an accurate serological test that 
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The Zika virus epidemic that started in Brazil has led to 
thousands of cases of devastating neuropathology and 
miscarriage, stillbirth, and neonatal death. Although 
the US Centers for Disease Control and Prevention 
has concluded that Zika virus causes microcephaly 
and other fetal brain defects,1 demonstration of Zika 
virus in tissues is sparse. In The Lancet, Roosecelis Brasil 
Martines and colleagues’ case series2 documents Zika 
viral infection and pathology in three autopsy cases and 
two spontaneous abortions and is the ﬁ rst study we are 
aware of linking Zika virus to congenital malformations. 
Samples from ﬁ ve cases, including two newborn 
babies with microcephaly and severe arthrogryposis 
who died shortly after birth, one 2-month-old baby, 
and two placentas from spontaneous abortions, from 
Brazil were assessed by pathological examination, 
immunohistochemical assays using a mouse anti-Zika 
virus antibody, and RT-PCR assays targeting the NS5 
and envelope genes. Amplicons of RT-PCR positive 
cases were sequenced for characterisation of strains. 
The authors’ case series includes details necessary to 
formulate pathogenic hypotheses but prompts new 
mechanistic questions.
A major ﬁ nding in Zika virus transmission is 
the relation between ﬁ rst trimester exposure and 
severe sequelae, similar to that seen for congenital 
rubella syndrome. Because maternal perfusion of 
the placenta does not occur until late ﬁ rst to second 
trimester, the mechanism of transplacental infection 
is not straightforward. Is there direct infection of the 
trophoblast (as shown in animal and in-vitro studies3) 
that transmits virus to developing neural tissue?4 
Martines and colleagues’2 ﬁ nding of Zika virus in early 
placenta supports a direct mechanism.
A placental pathological footprint of viral infection is 
crucial information providing diagnostic and causational 
data. Martines and colleagues2 describe three placentas, 
one from each trimester. The placental ﬁ ndings varied 
by trimester with virus identiﬁ ed in the ﬁ rst and 
second trimester placenta. Histopathological features 
were present only in the ﬁ rst trimester placenta. This 
11-week gestational age placenta showed a speciﬁ c 
pathological entity, chronic histiocytic intervillositis—a 
striking histopathology of unknown cause diagnosed 
by substantial intervillous histiocytosis (presumed to 
be maternally derived) admixed with intervillous ﬁ brin.5 
Zika and histopathology in ﬁ rst trimester infections
could be incorporated into routine prenatal care will be 
essential, and its validation a research priority.
Besides all these issues, the main message of the paper 
is important for health surveillance measures: focusing 
only on microcephaly is insuﬃ  cient to detect all aﬀ ected 
newborn babies, and a revision of the procedures 
should be accomplished. While the current outbreak 
is a paradigmatic example of how quickly evolving 
systematic scientiﬁ c evidence can (and should) change 
the view on a disease within months, it can be expected 
that public health authorities, and also the scientiﬁ c 
community, will struggle for many years with Zika 
epidemics and its consequences in Brazil and elsewhere.
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